EP
ETON icon

Essential Partners’s Eton Pharmaceutcials ETON Stock Holding History

Essential Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36 Buy
+1
New +$29 ﹤0.01% 2807

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Essential Partners's ETON Position: Q2 2026 in Review

Essential Partners opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 1 share worth $36. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings.

165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Essential Partners held 1 share of Eton Pharmaceutcials worth $36 as of Q2 2026.
  • Eton Pharmaceutcials was a new Essential Partners position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2807 holding.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.